BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - April 25, 2025

  April 28, 2025

   · 

  3 min read
• Press Releases

  Apnimed Expands Portfolio of Oral Pharmacotherapies for Sleep and Breathing Diseases Through Acquisition of Global Rights to Patents Covering Sulthiame, a Differentiated Carbonic Anhydrase Inhibitor

  April 28, 2025

   · 

  6 min read
• Press Releases

  ReAlta Life Sciences Announces New Clinical Data for RLS-0071 (pegtarazimod) from Hypoxic Ischemic Encephalopathy Program at Pediatric Academic Societies 2025 Meeting

  April 28, 2025

   · 

  5 min read
• Press Releases

  Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

  April 28, 2025

   · 

  1 min read
• Press Releases

  AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO

  April 28, 2025

   · 

  8 min read
• Press Releases

  Parabilis Medicines Reports Positive Proof-of-Mechanism Data for Groundbreaking ERG Degrader Program

  April 28, 2025

   · 

  3 min read
• Press Releases

  Tevogen Bio Announces 2025 Annual Meeting

  April 28, 2025

   · 

  2 min read
• Press Releases

  Accent Therapeutics Presents Data Supporting Therapeutic Potential of First-in-Class DHX9 Inhibitor, ATX-559, and Novel KIF18A Inhibitor, ATX-295, at the AACR Annual Meeting 2025

  April 28, 2025

   · 

  6 min read
• Press Releases

  Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

  April 28, 2025

   · 

  1 min read
• Press Releases

  Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update

  April 28, 2025

   · 

  9 min read